Getting affordability right, without creating risk
Offering finance for Botox and other non-surgical aesthetic treatments can genuinely help patients manage costs, but it only works when it is set up legally, communicated transparently, and delivered in a way that protects the patient as much as the clinic.
In 2023-24, clinics have seen a noticeable rise in patients asking about payment plans as household budgets have tightened. At the same time, finance options have become easier to integrate at checkout, with platforms like Klarna, Clearpay and Payl8r expanding into aesthetics and reporting strong growth in this merchant category. That combination creates an opportunity, but also a regulatory responsibility.
The key point is simple: in the UK, offering credit, or even introducing a customer to a lender as part of a sale, can trigger Financial Conduct Authority (FCA) rules. Consumer Duty is also fully in force, which raises the bar on fair value, suitability and customer understanding. If a clinic gets this wrong, the downside is not just chargebacks or complaints - it can include enforcement action, fines, and reputational damage.
This guide breaks the topic down in plain English: the main finance models clinics use, what FCA compliance normally looks like in practice, how to market finance without breaching ASA and FCA rules, and how to build a patient journey that is both conversion-friendly and ethically sound.
The clinics this guide is written for
This is for UK aesthetics businesses that want to offer patients a way to spread the cost of Botox, anti-wrinkle injections, and higher-ticket treatment plans - without stepping into avoidable regulatory trouble.
It is especially relevant if you are a clinic owner, practice manager, or front-of-house lead who is considering Buy Now, Pay Later (BNPL), 0% interest plans, or a specialist third-party lender. It will also help if you already mention "payment plans" on your website or social channels and want to be confident those messages are compliant.
If you are not FCA-authorised today, you are not alone. Most clinics choose a model where an FCA-authorised lender handles the regulated activity, while the clinic focuses on treatment, consent, and patient care.
What it actually means to “offer finance” for Botox
In practical terms, offering finance means giving patients a structured way to pay over time, usually through a third party who performs the credit checks, provides the credit agreement, and collects repayments. The clinic typically receives payment upfront (less a fee), while the lender manages the customer credit relationship.
There are a few common routes in UK aesthetics:
- BNPL at checkout - platforms such as Klarna, Clearpay and Payl8r can let eligible patients split the cost into instalments. The clinic registers as a merchant and pays a processing fee per transaction.
- Specialist healthcare and aesthetics lenders - providers such as Payl8r, Chrysalis Finance, Medpay and Kandoo are built around regulated finance workflows for clinics, including digital applications, affordability checks, and compliant documentation.
- 0% interest promotional finance - the patient pays no interest, and the clinic funds the cost of credit via a merchant subsidy fee (often in the low single digits as a percentage of the basket).
It is important to separate the commercial idea of “letting someone pay monthly” from the legal definition of credit. If the arrangement is regulated consumer credit, advertising rules apply, pre-contract information is required (typically via a SECCI document), and the patient must have the protections that UK law provides.
How clinics typically set it up in a compliant way
Most clinics reduce compliance burden by partnering with an FCA-authorised third-party lender. In that model, the lender controls the regulated process: eligibility checks, the credit agreement, mandatory disclosures, and collections. The clinic’s role is kept tightly defined, often as an introducer or appointed representative arrangement, depending on the provider’s structure and permissions.
A practical setup often looks like this:
- The clinic chooses a finance partner whose product fits typical treatment values, from single Botox sessions to higher-ticket combination packages.
- The lender provides a digital application journey, usually via a link or QR code that the patient can complete on their phone.
- Increasingly, the journey starts with a soft-search eligibility check. This does not leave a footprint on the patient’s credit file, which can reduce anxiety and drop-off. In aesthetics, some providers report approval rates around 70-85% for applicants using these workflows.
- If the patient proceeds, they receive the required pre-contract information and the full credit agreement, including the APR where relevant.
- The clinic builds clear internal scripts and training so staff can explain options factually without pressuring anyone.
A good rule of thumb: the clinic should explain payment options clearly, but the lender should own the credit decision, affordability assessment, and regulated documentation.
Why finance can lift conversions, when used responsibly
For treatments above roughly £300, clinics often find that finance reduces “sticker shock” and makes it easier for patients to proceed with a plan they already want, rather than delaying or abandoning. Industry surveys commonly suggest that offering 0% finance can improve conversion rates by around 20-40% for higher-ticket aesthetic procedures and packages.
From a business point of view, finance can support:
- Higher acceptance of premium plans - patients may choose combination treatments or structured courses of care when the monthly cost feels manageable.
- More predictable scheduling - patients who are approved and committed to a plan are often less likely to postpone.
- A clearer patient experience - if affordability questions are handled openly and early, fewer conversations end with “I’ll think about it” caused purely by payment uncertainty.
The trade-off is cost and governance. 0% finance is rarely free to the clinic. Many clinics fund it via a merchant subsidy fee, often around 2-6% of the transaction value, depending on term length and provider.
Just as importantly, the FCA’s Consumer Duty expectations mean clinics need to be able to show that the overall outcome for the patient is fair, transparent and not driven by pressure. Done properly, finance is not a sales tactic - it is an accessibility tool with guardrails.
Pros and cons at a glance
| Option | Main advantages | Main drawbacks | Best fit for |
|---|---|---|---|
| BNPL (e.g., Klarna, Clearpay, Payl8r) | Fast checkout-style instalments, familiar to younger patients, simple merchant setup | Not suitable for every patient, fees apply, still needs careful financial promotions compliance | Lower to mid-ticket treatments and clinics wanting a friction-light option |
| Specialist third-party lender (e.g., Payl8r, Chrysalis Finance, Medpay, Kandoo) | Lender handles credit checks, compliance docs, repayments and collections; often built for clinics | Provider fees and contractual requirements; your team still needs training and compliant scripts | Clinics wanting a robust, scalable finance journey with reduced regulatory exposure |
| 0% promotional finance (funded by clinic) | Strong conversion lever; easier for patients to understand than interest-bearing credit | Clinic pays a subsidy fee (often 2-6%); must ensure fair value and clear disclosures | Higher-ticket packages where conversion uplift can justify the cost |
| In-house payment plan (clinic-managed) | Full control of terms and customer relationship | High regulatory and operational risk; collections burden; may require FCA permissions | Generally not recommended unless you have specialist compliance support |
| Membership or subscription (non-credit) | Spreads cost without typical consumer credit regulation triggers; improves retention | Needs careful design to avoid becoming credit; may not suit one-off treatments | Clinics wanting “finance-lite” affordability and predictable monthly revenue |
The compliance and patient-care traps to avoid
The biggest risk is accidentally acting as a credit broker without the right FCA permissions. In the UK, introducing a patient to a lender as part of arranging credit can be regulated activity, and the FCA has been clear that Consumer Duty requires firms to deliver good outcomes, not just provide paperwork.
There are also specific communication and advertising obligations. Under the Consumer Credit Act 1974 and FCA rules, patients must receive clear pre-contract information (commonly via a SECCI form), and any financial promotion must be fair, clear and not misleading. If you advertise interest-bearing finance, you typically need to show a representative APR prominently. The Advertising Standards Authority (ASA) also warns against promoting finance in a way that trivialises debt, particularly for medical-style procedures.
Operationally, clinics should watch for:
- Pressure selling - finance should never be positioned as a way to overcome hesitation or make a patient “able” to proceed.
- Vulnerable customer risk - Consumer Duty expects you to consider vulnerability. In aesthetics, that can include financial vulnerability and wellbeing concerns. Industry guidance, including from bodies such as the JCCP, supports strong safeguards.
- Cooling-off clarity - regulated credit agreements usually come with a 14-day right to withdraw. Patients should understand what that means in real terms.
- Unreviewed social posts - lenders often offer compliance review of finance messaging. Use it, especially for paid ads and Instagram-style promotions.
If your finance offer is easy to sell but hard to explain, treat that as a warning sign, not a marketing challenge.
Alternatives that can improve affordability without credit
- Monthly membership schemes (for example £49-£99 per month) that bundle consultations, top-ups, or skincare benefits, using platforms like Pabau, Fresha, or a bespoke direct debit setup.
- Treatment packages paid upfront with a small discount (clear terms, clear expiry, no credit element).
- Deposit-based booking with staged payments before treatment (structured as payment timing, not lending).
- Third-party gift cards or vouchers for planned treatments (ensure terms are transparent and fair).
- Employer benefit partnerships where applicable, if you serve corporate clients and can offer wellbeing-style allowances.
FAQs clinics ask before adding Botox finance
Often, yes, if you are arranging credit or acting as a credit broker. Many clinics avoid holding their own permissions by working with an FCA-authorised lender via an appointed-representative or introducer setup. Get written clarification from the lender and, where needed, independent compliance advice.
Can we use BNPL for Botox?
Some BNPL providers do support aesthetics merchants, and uptake has grown as patients look to spread costs. You still need to treat any finance messaging as a financial promotion and make sure it is accurate, balanced, and includes required information.
What is the difference between 0% finance and BNPL?
0% finance is a credit agreement where the patient pays no interest, and the clinic usually funds the cost via a merchant subsidy fee. BNPL is typically a short-term instalment product offered at checkout, subject to eligibility, with its own fee structure and terms.
How much can 0% finance improve conversions?
Surveys in the sector commonly cite conversion uplifts in the 20-40% range for treatments above about £300, but results vary by clinic, pricing, and how the option is presented. It should be offered as a choice, not a nudge.
Are soft-search checks better for the patient journey?
They can be. Soft-search eligibility checks generally do not leave a mark on the customer’s credit file, which can reduce drop-off. Some aesthetics providers report approval rates around 70-85% among applicants using these flows.
What must we include in finance advertising?
If you mention finance in ads, website banners, or social posts, the message must be fair, clear and not misleading. For interest-bearing credit you will usually need to show a representative APR, and you must not use language that trivialises debt. Many clinics ask their lender’s compliance team to review copy before publication.
Can a membership scheme avoid consumer credit regulation?
Often, yes, if it is genuinely a subscription for services or benefits and not structured as lending. Design matters. If you are unsure, get advice and keep terms simple and transparent.
How should we handle vulnerable customers?
Have a written policy, train staff, and make it clear finance is optional. Do not use finance to overcome affordability objections. Ensure patients understand cooling-off rights and have space to decide, especially for elective treatments.
How Switcha can help
Switcha is a UK price comparison website. If you are exploring ways to offer patient finance, we can help you compare providers and understand key differences in plain English - such as fees, typical terms, onboarding speed, soft-search journeys, and what compliance support is included. We focus on clarity, so you can shortlist options that fit your clinic model and risk appetite before you commit to any partnership.
Disclaimer
This article is for general information only and does not constitute financial, legal, or regulatory advice. FCA rules and their application can vary by business model and specific arrangements with lenders. You should confirm requirements with an FCA-authorised provider and consider independent compliance or legal advice before offering credit or advertising finance.
